{"id":"W3213647691","doi":"10.1161/jaha.121.021094","title":"Blood Pressure and Safety Events With Vericiguat in the VICTORIA Trial","year":2021,"lang":"en","type":"article","venue":"Journal of the American Heart Association","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta","funders":"Rijksuniversiteit Groningen; University of Glasgow; Duke Clinical Research Institute; Uniwersytet Medyczny im. Piastów Slaskich we Wroclawiu; University of Alberta; Duke-NUS Medical School; Bayer","keywords":"Blood pressure; Heart failure; Tolerability; Valsartan; Ejection fraction; Angiotensin receptor; Clinical endpoint; Sacubitril; Clinical trial","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002772555,0.0002249755,0.0008277009,0.0001674471,0.0003117803,0.0008021799,0.0005169373,0.0006613406,0.00185167],"category_scores_gemma":[0.005184683,0.0001910475,0.001063472,0.0005270937,0.0003920012,0.0004375429,0.0006241621,0.001273596,0.0001531094],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001447119,"about_ca_system_score_gemma":0.002327031,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01115124,"about_ca_topic_score_gemma":0.0310585,"domain_scores_codex":[0.9981212,0.001192736,0.0001066143,0.0001754977,0.000193067,0.0002108465],"domain_scores_gemma":[0.9978453,0.0004716423,0.0008289236,0.0001480953,0.000149016,0.0005569616],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.6276835,0.002376202,0.1486813,0.004867771,0.008374389,0.0003022114,0.0004903711,0.002970402,0.003626771,0.002113462,0.01351831,0.1849952],"study_design_scores_gemma":[0.2064527,0.05217731,0.7082012,0.001721574,0.007568331,0.000461913,0.0003017196,0.004707863,0.001058541,0.00297553,0.01419739,0.0001761154],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9726641,0.0190674,0.0002335606,0.001366278,0.0001224439,0.0002817762,0.001582179,0.00002604159,0.004656214],"genre_scores_gemma":[0.994217,0.002442214,0.0003817671,0.0006574785,0.00008641235,0.0002219461,0.001064797,0.000007600649,0.0009207784],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01115124,"threshold_uncertainty_score":0.02217263,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008411893688181377,"score_gpt":0.2653948737098364,"score_spread":0.2569829800216551,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}